Notice of allowance issued for central nervous system peptide technology

New york, july 27, 2021 /prnewswire/ -- aikido pharma inc. (nasdaq: aiki) ("aikido" or the "company") today announced that the u.s. patent and trademark office has issued a notice of allowance for application no.: 16/477,125.

DOMH Ratings Summary

DOMH Quant Ranking